We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+25.02%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$9.25M
Cap. Flow
-$40.5M
Cap. Flow %
-12.03%
Top 10 Hldgs %
39.7%
Holding
90
New
18
Increased
16
Reduced
19
Closed
33

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$9.77M
2
ELV icon
Elevance Health
ELV
+$8.59M
3
BDX icon
Becton Dickinson
BDX
+$7.65M
4
LLY icon
Eli Lilly
LLY
+$7.47M
5
ABBV icon
AbbVie
ABBV
+$6.73M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$10.8M
2
MRK icon
Merck
MRK
+$8.29M
3
ZBH icon
Zimmer Biomet
ZBH
+$6.81M
4
DNLI icon
Denali Therapeutics
DNLI
+$6.5M
5
SNY icon
Sanofi
SNY
+$6.27M

Sector Composition

Rank Sector Weight
1 Healthcare 91.04%
2 Energy 4.31%
3 Financials 0.52%
4 Consumer Discretionary 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRTC icon
76
iRhythm Holdings
IRTC
$4.04B
– –
-12,000
Closed -$2.86M
MCRB icon
77
Seres Therapeutics
MCRB
$46.5M
– –
-1,500
Closed -$849K
MOH icon
78
Molina Healthcare
MOH
$10.3B
– –
-15,000
Closed -$2.75M
MRK icon
79
Merck
MRK
$324B
– –
-104,800
Closed -$8.29M
MRNA icon
80
PUT
Moderna
MRNA
$24.7B
– –
-50,000
Closed -$3.54M
PODD icon
81
Insulet
PODD
$9.7B
– –
-22,000
Closed -$5.21M
SNY icon
82
Sanofi
SNY
$105B
– –
-125,000
Closed -$6.27M
UHS icon
83
Universal Health Services
UHS
$9.88B
– –
-30,000
Closed -$3.21M
ZBH icon
84
Zimmer Biomet
ZBH
$18.1B
– –
-51,500
Closed -$6.81M
ONC
85
BeOne Medicines Ltd
ONC
$40.4B
– –
-14,500
Closed -$4.15M
CTLT
86
DELISTED
CATALENT, INC.
CTLT
– –
-35,000
Closed -$3M
CHNG
87
DELISTED
Change Healthcare Inc. Common Stock
CHNG
– –
-50,000
Closed -$726K
DRNA
88
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-80,000
Closed -$1.44M
GNMK
89
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-125,000
Closed -$1.77M
HZNP
90
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-30,000
Closed -$2.33M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Integral Health Asset Management held 90 positions worth $336M, up 2.8% from $327M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Integral Health Asset Management withdrew a net $40.5M in Q4 2020, closing 33 positions and reducing 19 holdings. Its most notable exit was Humana, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 85% a quarter earlier, followed by Energy and Financials.

Against the trend, Integral Health Asset Management opened a new position in Elevance Health worth $8.99M.

  • Integral Health Asset Management's largest Q4 2020 buy was Elevance Health: 28,000 shares worth $8.99M.
  • Integral Health Asset Management added most to Acadia Healthcare in Q4 2020, an estimated $9.77M increase.
  • Integral Health Asset Management's biggest Q4 2020 reduction was Denali Therapeutics, cutting an estimated $6.5M.
  • Integral Health Asset Management fully exited Humana in Q4 2020, selling an estimated $10.8M.
  • Integral Health Asset Management's ten largest holdings make up 40% of its $336M portfolio in Q4 2020.
  • Integral Health Asset Management opened 18 new positions and closed 33 in Q4 2020.
  • Integral Health Asset Management's portfolio value rose 2.8% quarter-over-quarter to $336M.

Based on Integral Health Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.